Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898)
Type:
Grant
Filed:
October 22, 2004
Date of Patent:
December 26, 2006
Assignee:
Sanofi-Aventis Deutschland GmbH
Inventors:
Holger Hoffmann, Sabine Haag-Richter, Michael Kurz, Heiko Tietgen